How far are we from understanding the genetic basis of hashimoto's thyroiditis

International Reviews of Immunology

Volumn 32, Issue 3, 2013, Pages 337-354

  Jabrocka Hybel, Agata ^a   Skalniak, Anna ^a   Piatkowski, Jakub ^a   Pach, Dorota ^a   Hubalewska Dydejczyk, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

AITD; Autoimmunity; Candidate genes; Gene interactions

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DRB4 ANTIGEN; LEUKOCYTE ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PENDRIN; THYROGLOBULIN; TRANSCRIPTION FACTOR SOX4;

ARTICLE; AUTOPHOSPHORYLATION; CHROMOSOME 1Q; CHROMOSOME 5; CHROMOSOME 8; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENOME; GRAVES DISEASE; HAPLOTYPE; HASHIMOTO DISEASE; HLA SYSTEM; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; THYROID HORMONE SYNTHESIS;

ANIMALS; ANTIGENS, CD; CTLA-4 ANTIGEN; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HASHIMOTO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; POLYMORPHISM, GENETIC; TRANSCRIPTOME;

EID: 84879105366     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2012.755175     Document Type: Article

References (106)

1. Jaume JC. Chapter 3, Endocrine Autoimmunity. In: Gardner D, Shoback D, editors. Greenspan' basic & clinical endocrinology. 8th ed. New York:McGraw-Hill; 2007. pp. 59-79.
2. Staii A, Mirocha S, Todorova-Koteva K, et al. Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Res 2010;3(1): 11-17.
3. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001;2(9):777-780.
4. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: Fromgene mapping to gene function. Endocr Rev 2003;24(5):694-717.
5. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995;43(1): 55-68.
6. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease: A population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001;86(2):930-934.
7. Hansen PS, Brix TH, Iachine I, et al.The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: A study of healthy Danish twins. Eur J Endocrinol 2006;154(1):29-38.
8. Ban Y, Greenberg DA, Davies TF, et al. 'Linkage analysis of thyroid antibody production: Evidence for shared susceptibility to clinical autoimmune thyroid disease. J Clin Endocrinol Metab 2008;93(9):3589-3596.
9. Hall R, Stanbury JB. Familial studies of autoimmune thyroiditis. Clin Exp Immunol 1967;2(Suppl):719-725.
10. Tomer Y, Ban Y, Concepcion E, et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: Results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003;73(4):736-747.
11. Vaidya B, Kendall-Taylor P, Pearce SH. The genetics of autoimmune thyroid disease. J Clin EndocrinolMetab 2002;87(12):5385-5397.
12. Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 2003;36(6-7):367-379.
13. Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis. J Autoimmune Dis 2005;2(1):1.
14. Zeitlin AA, Heward JM, Newby PR, et al. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes Immun 2008;9(4):358-363.
15. Allahabadia A, Gough SC.The different approaches to the genetic analysis of autoimmune thyroid disease. J Endocrinol 1999;163(1):7-13.
16. Sakai K, Shirasawa S, Ishikawa N, et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 andHashimoto's thyroiditis to 8q23-q24 bymultipoint affected sib-pair linkage analysis in Japanese. HumMol Genet 2001;10(13):1379-1386.
17. Allen EM, Hsueh WC, Sabra MM, et al. A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: Replication of genetic linkage on chromosome5q11.2-q14.3. J Clin EndocrinolMetab 2003;88(3):1292-1296.
18. Alkhateeb A, Stetler GL, Old W, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. HumMol Genet 2002;11(6):661-667.
19. Tomer Y, Barbesino G, Greenberg DA, et al. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions. J Clin EndocrinolMetab 1999;84(12):4656-4664.
20. Smyth D, Cooper JD, Collins JE, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004;53(11):3020-3023.
21. Forabosco P, Bouzigon E, Ng MY, et al. Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet 2009;17(2):236-243.
22. Criswell LA, Pfeiffer KA, LumRF, et al. Analysis of families in themultiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates withmultiple autoimmune phenotypes. AmJ HumGenet 2005;76(4):561-567.
23. Taylor JC, Gough SC, Hunt PJ, et al. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin EndocrinolMetab 2006;91(2):646-653.
24. Tomer Y, Barbesino G, Greenberg DA, et al. A newGraves disease-susceptibility locusmaps to chromosome 20q11.2. international consortium for the genetics of autoimmune thyroid disease. Am J HumGenet 1998;63(6):1749-1756.
25. Eschler DC, Hasham A, Tomer Y. Cutting edge:The etiology of autoimmune thyroid diseases. Clin Rev Allergy Immunol 2011;41(2):190-197.
26. Stefan M, Jacobson EM, Huber AK, et al. Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem 2011;286(36):31168-31179.
27. Weetman AP. Autoimmune thyroid disease: Propagation and progression. Eur J Endocrinol 2003;148(1):1-9.
28. Ueda H,Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423(6939):506-511.
29. Hunt PJ, Marshall SE, Weetman AP, et al. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol (Oxf) 2001;55(4):491-499.
30. Jacobson EM, Yang H, Menconi F, et al. Employing a recombinant HLA-DR3 expression system to dissectmajor histocompatibility complex II-thyroglobulin peptide dynamism: A genetic, biochemical, and reverse immunological perspective. J Biol Chem 2009;284(49):34231-34243.
31. BrandO,Gough S,Heward J. HLA, CTLA-4 and PTPN22:The shared geneticmaster-key to autoimmunity? Expert RevMolMed 2005;7(23):1-15.
32. Muller-Hilke B, Mitchison NA. The role of HLA promoters in autoimmunity. Curr Pharm Des 2006;12(29):3743-3752.
33. Ban Y, Davies TF, Greenberg DA, et al.The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): Results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 2002;57(1):81-88.
34. Ban Y, Davies TF, Greenberg DA, et al. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 2004;5(3):203-208.
35. Menconi F, Monti MC, Greenberg DA, et al. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci USA 2008;105(37):14034-14039.
36. Kokaraki G, Daniilidis M, Yiangou M, et al. Major histocompatibility complex class II (DRB1?, DQA1?, andDQB1?) andDRB1?04 subtypes' associations ofHashimoto's thyroiditis in aGreek population. Tissue Antigens 2009;73(3):199-205.
37. Jenkins D, Penny MA, Fletcher JA, et al. HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1992;37(2):141-145.
38. Bogner U, Badenhoop K, Peters H, et al. HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 1992;14(2):155-158.
39. Menconi F, Osman R,Monti MC, et al. Sharedmolecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci USA 2010;107(39):16899-16903.
40. Hodge SE, Ban Y, Strug LJ, et al. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease.Thyroid 2006;16(4):351-355.
41. Cooper D, Greenspan F, Ladenson P. Chapter 8, The Thyroid Gland. In: Gardner D, Shoback D, editors. Greenspan's basic & clinical endocrinology. 8th ed. New York: McGraw-Hill; 2007. pp. 209-280.
42. Siggs OM, Miosge LA, Yates AL, et al. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 2007;27(6):912-926.
43. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36(4):337-338.
44. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75(2):330-337.
45. Hasegawa K,Martin F, Huang G, et al. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004;303(5658):685-689.
46. Zoledziewska M, Perra C, Orru V, et al. Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes. Diabetes 2008;57(1):229-234.
47. Viken MK, Amundsen SS, Kvien TK, et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005;6(3):271-273.
48. Kyogoku C, Langefeld CD, Ortmann WA, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004;75(3): 504-507.
49. Velaga MR, Wilson V, Jennings CE, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004;89(11):5862-5865.
50. Skorka A, Bednarczuk T, Bar-Andziak E, et al. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: Association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 2005;62(6):679-682.
51. Skinningsrud B, Husebye ES, Gervin K, et al. Mutation screening of PTPN22: Association of the 1858T-allele with Addison's disease. Eur J Hum Genet 2008;16(8):977-982.
52. Lee YH, Rho YH, Choi SJ, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford) 2007;46(1):49-56.
53. Canton I, Akhtar S, GavalasNG, et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 2005;6(7):584-587.
54. DultzG,Matheis N, DittmarM, et al.Theprotein tyrosine phosphatase non-receptor type 22C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.Thyroid 2009;19(2):143-148.
55. Wu H, Cantor RM, Graham DS, et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: Increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005;52(8):2396-2402.
56. Ban Y, Tozaki T, Taniyama M, et al. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese.Thyroid 2005;15(10):1115-1118.
57. Kahles H, Ramos-Lopez E, Lange B, et al. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 2005;153(6):895-899.
58. Matesanz F, Rueda B, Orozco G, et al. Protein tyrosine phosphatase gene (PTPN22) polymorphism inmultiple sclerosis. J Neurol 2005;252(8):994-995.
59. Begovich AB, Caillier SJ, Alexander HC, et al. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 2005;76(1): 184-187.
60. De Jager PL, Sawcer S, Waliszewska A, et al. Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis. Eur J Hum Genet 2006;14(3):317-321.
61. van OeneM,Wintle RF, Liu X, et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005;52(7):1993-1998.
62. Vang T,Miletic AV, Bottini N,Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007;40(6):453-461.
63. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40(8):955-962.
64. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37(12):1317-1319.
65. RieckM,ArechigaA,Onengut-GumuscuS, et al.Genetic variation inPTPN22corresponds to altered function of T and B lymphocytes. J Immunol 2007;179(7):4704-4710.
66. Arechiga AF, Habib T, He Y, et al. Cutting edge:The PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 2009;182(6):3343-3347.
67. Zikherman J, Hermiston M, Steiner D, et al. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J Immunol 2009;182(7): 4093-4106.
68. Carlton VE,Hu X, Chokkalingam AP, et al. PTPN22 genetic variation: Evidence formultiple variants associated with rheumatoid arthritis. AmJ HumGenet 2005;77(4):567-581.
69. Orru V, Tsai SJ, Rueda B, et al. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. HumMol Genet 2009;18(3):569-579.
70. Rodriguez-Rodriguez L, Taib WR, Topless R, et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum 2011;63(2): 365-372.
71. Luo L, Cai B, Liu F, et al. Association of protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T gene polymorphism with susceptibility to autoimmune thyroid diseases: A meta-analysis. Endocr J 2012;59(5):439-445.
72. Kavvoura FK, Akamizu T, Awata T, et al. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: A meta-analysis. J Clin Endocrinol Metab 2007;92(8):3162-3170.
73. Nithiyananthan R,Heward JM, Allahabadia A, et al. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.Thyroid 2002;12(1):3-6.
74. Heward JM, Allahabadia A, ArmitageM, et al. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin EndocrinolMetab 1999;84(7):2398-2401.
75. Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 1997;82(12):4130-4132.
76. Zaletel K, Krhin B, Gaberscek S, Hojker S.Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients withHashimoto's thyroiditis. Int J Immunogenet 2006;33(2):87-91.
77. Zaletel K, Krhin B, Gaberscek S, et al. Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphismwith thyroid autoantibody production in patientswithHashimoto's and postpartum thyroiditis. Clin Exp Immunol 2010;161(1):41-47.
78. Bicek A, Zaletel K, Gaberscek S, et al. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Hum Immunol 2009;70(10):820-824.
79. Yesilkaya E, Koc A, Bideci A, et al. CTLA4 gene polymorphisms in children and adolescents with autoimmune thyroid diseases. Genet Test 2008;12(3):461-464.
80. Petrone A, Giorgi G, Mesturino CA, et al. Association of DRB1?04-DQB1?0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population.Thyroid 2001;11(2):171-175.
81. SahinM, Gursoy A, Erdogan MF. Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis. Int J Immunogenet 2009;36(2):103-106.
82. Inoue N, Watanabe M, Yamada H, et al. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J Clin Immunol 2012;32(6): 1243-1252.
83. Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997;46(5):551-554.
84. Jacobson EM, Tomer Y.The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the future. J Autoimmun 2007;28(2-3): 85-98.
85. Caputo M, Rivolta CM, Mories T, et al. Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis. Endocrine 2010;37(3):389-395.
86. Collins JE, Heward JM, Carr-Smith J, et al. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab 2003;88(10): 5039-5042.
87. Ban Y, Greenberg DA, Concepcion E, et al. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci USA 2003;100(25):15119-15124.
88. Collins JE, Heward JM, Howson JM, et al. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J Clin EndocrinolMetab 2004;89(12):6336-6339.
89. Ban Y, Tozaki T, TaniyamaM, et al.Multiple SNPs in intron 41 of thyroglobulin gene are associated with autoimmune thyroid disease in the Japanese population. PLoS One 2012;7(5):e37501.
90. Anker R, Steinbrueck T, Donis-Keller H. Tetranucleotide repeat polymorphism at the human thyroid peroxidase (hTPO) locus. HumMol Genet 1992;1(2):137.
91. PirroMT, De Filippis V, Di Cerbo A, et al.Thyroperoxidase microsatellite polymorphism in thyroid diseases.Thyroid 1995;5(6):461-464.
92. Belguith-Maalej S, Rebuffat SA, Charfeddine I, et al. SLC26A4 expression among autoimmune thyroid tissues. Immunobiology 2011;216(5):571-578.
93. Hadj Kacem H, Rebai A, Kaffel N, et al. PDS is a new susceptibility gene to autoimmune thyroid diseases: Association and linkage study. J Clin EndocrinolMetab 2003;88(5):2274-2280.
94. Hadj-Kacem H, Kallel R, Belguith-Maalej S, et al. SLC26A4 variations among Graves' hyperfunctioning thyroid gland. DisMarkers 2010;29(2):63-69.
95. Yoshida A,Hisatome I, Taniguchi S, et al. Pendrin is a novel autoantigen recognized by patientswith autoimmune thyroid diseases. J Clin EndocrinolMetab 2009;94(2):442-448.
96. Tomer Y. Genetic susceptibility to autoimmune thyroid disease: Past, present, and future.Thyroid 2010;20(7):715-725.
97. Vieland VJ,Huang Y, Bartlett C, et al. Amultilocusmodel of the genetic architecture of autoimmune thyroid disorder, with clinical implications. AmJ HumGenet 2008;82(6):1349-1356.
98. Terauchi M, Yanagawa T, Ishikawa N, et al. Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population. J Endocrinol Invest 2003;26(12):1208-1212.
99. Plenge RM, Padyukov L, Remmers EF, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005;77(6):1044-1060.
100. Baki M,Akman FE, Vural P, et al.Thecombination of interleukin-10-1082 and tumor necrosis factor alpha-308 or interleukin-6-174 genes polymorphisms suggests an association with susceptibility to Hashimoto's thyroiditis. Int Immunopharmacol 2012;12(4):543-546.
101. Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. J Autoimmun 2009;33(3-4):183-189.
102. Duntas LH. Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 2008;4(8):454-460.
103. Guarneri F, Carlotta D, Saraceno G, et al. Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor.Thyroid 2011;21(11):1283-1284.
104. Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010;34(3):J322-J326.
105. Morohoshi K, Takahashi Y, Mori K. Viral infection and innate pattern recognition receptors in induction of Hashimoto's thyroiditis. DiscovMed 2011;12(67):505-511.
106. Carle A, Pedersen IB, KnudsenN, et al.Thyroid volume in hypothyroidism due to autoimmune disease follows a unimodal distribution: Evidence against primary thyroid atrophy and autoimmune thyroiditis being distinct diseases. J Clin EndocrinolMetab 2009;94(3):833-839.